Teucrium Soybean Fund (SOYB) Financials

SOYB

FY2025 annual

Revenue Not reported for FY2025

Net Income -$26.5M +44.6% YoY

EPS (Diluted) Not reported for FY2025

Free Cash Flow Not reported for FY2025

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 11, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SOYB SEC filings page.

This page shows Teucrium Soybean Fund (SOYB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SOYB FY2025 2026-08-30

Reported profitability has shifted into persistent cash outflows, while the balance sheet remains predominantly equity-funded.

In FY2021, net income of $82.4M sat close to operating cash flow of $75.2M, indicating reasonable cash conversion. By FY2024, both were negative—net income of -$47.9M and operating cash flow of -$39.4M—showing that the weaker earnings profile was accompanied by weaker operating cash economics.

FY2022 reported share buybacks reached $935M while operating cash flow was -$106.3M, making capital allocation a major driver of cash movement rather than operations alone. Despite liabilities rising, debt-to-equity remained below 0.1x through FY2024, leaving the funding structure primarily equity-based.

The latest net loss narrowed to -$26.5M in FY2025 from -$47.9M the prior year, but the period has no operating-cash-flow or balance-sheet figures. That apparent improvement therefore cannot yet be tested for cash conversion or leverage.

Financial Health Signals

Financial health score not available

Teucrium Soybean Fund does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income

$30.4M

YoY+1077.9%

QoQ+1077.9%

Teucrium Soybean Fund reported $30.4M in net income in Q1 2026. This represents an increase of 1077.9% from the same quarter a year earlier. Against the prior quarter it is up 1077.9%.

Revenue

Not reported for Q1 2026.

EBITDA

Not reported for Q1 2026.

EPS (Diluted)

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$641.4M

YoY+235.6%

QoQ+235.6%

Teucrium Soybean Fund held $641.4M in cash as of Q1 2026; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Shares Outstanding

Not reported for Q1 2026.

Margins & Returns

None of these metrics is reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

SOYB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SOYB quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	N/A	N/A	N/A	N/A	$88.6M+43.6%	$61.7M
SG&A Expenses	N/A	$327K+16.0%	$281K-13.0%	$323K+7.3%	$302K+1.3%	$298K
Interest Expense	N/A	$13.0M-26.8%	$17.7M+66.3%	$10.7M+1867.8%	$542K-59.9%	$1.4M
Net Income	-$26.5M+44.6%	-$47.9M+34.9%	-$73.5M+6.0%	-$78.2M-194.9%	$82.4M+46.8%	$56.2M

Metric	Q1'2610-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	N/A	N/A	N/A	$2.0M	N/A	N/A	$11.1M	N/A
SG&A Expenses	N/A	N/A	N/A	$71K+34.2%	$78K-36.8%	$71K+44.2%	$55K	$53K+12.9%
Interest Expense	N/A	N/A	N/A	$3.0M-34.3%	$3.5M-16.0%	$3.7M-14.5%	$4.6M	$4.6M+35.9%
Net Income	$30.4M+1077.9%	-$3.1M+86.8%	N/A	-$56K+99.8%	-$10.9M+52.1%	-$23.5M+22.8%	$8.8M	-$29.0M-416.0%
EPS (Basic)	N/A	N/A	N/A	N/A	N/A	$1.05-45.6%	N/A	N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax, EPS (Diluted), Diluted Shares (Avg).

SOYB Balance Sheet

SOYB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	N/A	$241.7M-25.9%	$326.0M-35.5%	$505.5M+89.9%	$266.3M	N/A
Cash & Equivalents	$205.3M-2.7%	$210.9M-27.8%	$292.2M-32.7%	$434.1M+72.1%	$252.2M-18.5%	$309.4M
Short-Term Investments	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0
Total Liabilities	N/A	$17.0M+49.4%	$11.4M-71.6%	$40.1M+1925.1%	$2.0M	N/A
Total Equity	N/A	$224.6M-28.6%	$314.5M-32.4%	$465.4M+76.1%	$264.3M	N/A

Metric	Q1'2610-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Total Assets	N/A	N/A	$241.7M-25.9%	$257.4M-30.2%	$268.0M-26.5%	$296.7M-24.4%	$326.0M-35.5%	$369.0M
Cash & Equivalents	$641.4M+235.6%	$191.2M-24.7%	$210.9M-27.8%	$233.3M-27.7%	$228.1M-26.7%	$253.7M-23.2%	$292.2M-32.7%	$322.5M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	N/A	N/A	$17.0M+49.4%	$10.2M-62.8%	$27.0M-40.6%	$18.9M-46.5%	$11.4M-71.6%	$27.4M
Total Equity	N/A	N/A	$224.6M-28.6%	$247.2M-27.6%	$241.0M-24.5%	$277.8M-22.2%	$314.5M-32.4%	$341.6M

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.

SOYB Cash Flow Statement

SOYB quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	N/A	-$39.4M+29.1%	-$55.6M+47.7%	-$106.3M-241.3%	$75.2M+41.5%	$53.1M
Financing Cash Flow	N/A	-$41.8M+51.5%	-$86.2M-129.9%	$288.1M+317.7%	-$132.3M-246.8%	$90.1M
Share Buybacks	N/A	$125.9M-52.5%	$264.9M-71.7%	$935.2M+214.0%	$297.8M+38.4%	$215.2M

Metric	Q1'2610-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Operating Cash Flow	N/A	N/A	N/A	-$1.6M+95.8%	$199K+103.3%	-$25.5M-50.2%	$5.6M	-$38.3M-67.9%
Financing Cash Flow	N/A	N/A	N/A	$6.9M-86.2%	-$25.8M-96.5%	-$13.1M+85.0%	-$35.9M	$49.8M+134.0%
Share Buybacks	N/A	N/A	N/A	$25.3M-34.2%	$47.8M-19.5%	$26.9M-75.8%	$56.4M	$38.4M-83.8%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid.

SOYB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SOYB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Net Margin	N/A	N/A	N/A	N/A	93.0%+2.0pp	91.0%
Return on Equity	N/A	-21.3%+2.1pp	-23.4%-6.6pp	-16.8%-48.0pp	31.2%	N/A
Return on Assets	N/A	-19.8%+2.7pp	-22.5%-7.1pp	-15.5%-46.4pp	30.9%	N/A
Debt-to-Equity	N/A	0.080.0x	0.040.0x	0.09+0.1x	0.01	N/A
Asset Turnover	N/A	-0.160.0x	-0.20-0.1x	-0.13-0.5x	0.33	N/A

Metric	Q1'2610-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Net Margin	N/A	N/A	N/A	-2.8%	N/A	N/A	79.3%	N/A
Return on Equity	N/A	N/A	N/A	0.0%+8.5pp	-4.5%+2.6pp	-8.5%+0.1pp	2.8%	-8.5%
Return on Assets	N/A	N/A	N/A	0.0%+7.8pp	-4.1%+2.2pp	-7.9%-0.2pp	2.7%	-7.9%
Debt-to-Equity	N/A	N/A	0.080.0x	0.040.0x	0.110.0x	0.070.0x	0.040.0x	0.08
Asset Turnover	N/A	N/A	N/A	0.01+0.1x	-0.030.0x	-0.070.0x	0.03	-0.07

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Where Teucrium Soybean Fund Ranks

Frequently Asked Questions

Is Teucrium Soybean Fund profitable?

No, Teucrium Soybean Fund (SOYB) reported a net income of -$26.5M in fiscal year 2025.